/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
North America’s Vision Guided Robotics Software Market to 2027: A $741 Million Opportunity – ResearchAndMarkets.com
Reading Time: 4 minutes
DUBLIN–(BUSINESS WIRE)–The “North
America Vision Guided Robotics Software Market to 2027 – Regional
Analysis and Forecasts by Robot Type, Technology, Application, and
Vertical” report has been added to ResearchAndMarkets.com’s
offering.
The North America vision guided robotics software market accounted for
US$ 230.81 Mn in 2018 and is expected to grow at a CAGR of 14.05% over
the forecast period 2019-2027, to account for US$ 741.85 Mn in 2027.
Factors including growing acceptance of vision guided robots are
significantly and high potential of mass customization driving the
vision guided robotics software market. However, lack of skilled
operator in the developing countries across region is impeding the
market growth.
Mounting demand of technological proficiencies of 3D machine vision is
opportunistic for the growth of the market. The industries are also
concentrating on the deployment of automation to ease their work.
In the last two decades, the company is inclined to integrate 2D vision
technology in robotics systems across several industries globally. To
meet the boosting requirement of the customers the industries are
focusing on advanced imaging technology to make the work easier and
simple.
Recently the robotic system is incorporated with 3D vision technology
which provides more features as compared to 2D vision technology. The
introduction of machine vision software into 3D vision-guided technology
robots is expected to increase the skills of the automated system during
random bin picking, packaging heavy materials and assembling different
parts of machinery among others.
The new capabilities of 3D vision-guided robots are they can detect the
overall orientation of an object which permits the end user to make an
intelligent and real-time decision associated with the automation system
depending upon the input of available visual data. The market players
are focusing on various initiatives to enhance its reach to rural areas
and boost its position in the market.
The vision guided robotics software market is fragmented with the
presence of several industries and the competitive dynamics in the
market is expected to change during the upcoming years. In addition to
this, various initiatives are undertaken by the governmental bodies to
accelerate the vision guided robotics software market further.
For instance, National Robotics Initiative 2.0, a cross-governmental
program that is built upon the original NRI. The program is intended to
accelerate the development and use of collaborative robots which will
work with humans and support them in various tasks.
The program supports four spheres for the research of the scalability,
customizability, lowering barriers to entry, and societal impact. The
program supports collaboration between academic, non-profit, industry,
and other organizations to increase the development. This initiative
provides various benefits to the US robotics companies, and thus
increasing the growth of vision-guided robotics market in the region.
These initiative provide various benefits to the US vision guided
robotics software based companies located in the region thus, increasing
the growth of vision guided robotics software markets. This initiative
provides multiple benefits to the companies present in this region and
thus increasing the growth of vision guided robotics software market in
the region.
On the basis of robot type, the fixed robot segment is leading the
vision guided robotics software market. However, the mobile robot
segment are anticipated to grow at a highest CAGR.
Mobile robots are fully autonomous or semi-autonomous machines capable
of locomotion in and around the defined workspace. These robots are
widely spread across various industries worldwide, due to the advantage
of movement and work along with humans, resulting in increase in working
efficiency.
The mobile robots are increasingly being adopted in industries such as
the automobile, aerospace, healthcare, warehouse logistics, and
transportation among others. Attributing to the application of mobile
robots in diversified sectors, the manufacturers are incorporating
machine vision software to enhance the movement capability. The
integration of high-end cameras, sensors, and software are anticipated
to double the adoption rate of mobile robots in the industries.
Key Topics Covered
Part 1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 North America Vision Guided Robotics Software Market – by Robot
Type
1.3.2 North America Vision Guided Robotics Software Market – by
Technology
1.3.3 North America Vision Guided Robotics Software Market – by
Application
1.3.4 North America Vision Guided Robotics Software Market – by Vertical
1.3.5 North America Vision Guided Robotics Software Market – by Country
Part 2. Key Takeaways
Part 3. Research Methodology
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
Part 4. North America Vision Guided Robotics Software Market
Landscape
4.1 Market Overview
4.2 Ecosystem Analysis
4.3 North America Pest Analysis
Part 5. North America Vision Guided Robotics Software Market –
Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Growing Acceptance of Vision Guided Robots
5.1.2 High Potential of Mass Customization
5.2 Key Market Restraints
5.2.1 Lack of Skilled Operator
5.3 Key Market Opportunity
5.3.1 Rising Technological Proficiencies of 3 D Machine Vision
5.4 Future Trends
5.4.1 Intuitive Programming Interfaces
5.5 Impact Analysis of Drivers and Restraints
Part 6. Vision Guided Robotics Software – North America Market
Analysis
6.1 North America Vision Guided Robotics Software Market Overview
6.2 North America Vision Guided Robotics Software Market Forecast and
Analysis
6.3 Market Positioning/ Market Share
Part 7. North America Vision Guide Robotics Software Market
Analysis – by Robot Type
7.1 Overview
7.2 North America Vision Guided Robotics Software Market Breakdown, by
Robot Type, 2018 & 2027
7.3 Fixed Robots
7.4 Mobile Robots
Part 8. North America Vision Guide Robotics Software Market
Analysis – by Technology
8.1 Overview
8.2 North America Vision Guided Robotics Software Market Breakdown, by
Technology, 2018 & 2027
8.3 D Vision Guided Technology
8.4 D Vision Guided Technology
Part 9. North America Vision Guide Robotics Software Market
Analysis – by Application
9.1 Overview
9.2 North America Vision Guided Robotics Software Market Breakdown, by
Application, 2018 & 2027
9.3 Arc Welding
9.4 Assembly
9.5 Cutting
9.6 Palletizing and Machine Tending
9.7 Navigation
9.8 Random Bin Picking
9.9 Collaborative Robots
9.10 Others
Part 10. North America Vision Guide Robotics Software Market
Analysis – by Vertical
10.1 Overview
10.2 North America Vision Guided Robotics Software Market Breakdown, by
Vertical, 2018 & 2027
10.3 Automotive
10.4 Electrical & Electronics
10.5 Aerospace
10.6 Healthcare
10.7 Transportation & Logistics
10.8 Food & Beverages
10.9 Others
Part 11. Vision Guided Robotics Software Market – Country
Analysis
11.1 North America Vision Guided Robotics Software Market Revenue and
Forecasts To 2027
Part 12. Industry Landscape
12.1 Market Initiative
12.2 Merger and Acquisition
12.3 New Development
Part 13. Vision Guided Robotics Software Market, Key Company
Profiles
13.1 ABB Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fanuc Corporation
13.3 Cognex Corporation
13.4 Automation Anywhere Inc.
13.5 Vision Guided Robotics LLC (VGR)
13.6 Robotic Vision Technologies Inc.
13.7 Bluewrist Inc.
13.8 Energid Technologies Corporation (Teradyne, Inc.)
13.9 iRobot Corporation
13.10 Asimov Robotics
13.11 Recognition Robotics
13.12 Ready Robotics Corporation
13.13 Pick-It N.V.
13.14 Mvtec Software GmbH
13.15 Visio Nerf S.A.
For more information about this report visit https://www.researchandmarkets.com/r/qfhdrw
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Software,
Robotics
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.
“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.
The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.
Disclaimer for Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, the occurrence of growth opportunities and the likelihood of growth potential.
Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.
The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East
Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.
The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Company Contacts:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]
Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]
Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html
-
StickIt2 weeks agoStickIt Technologies Inc. Announces Year-End 2023 Financial Results
-
Cannabis2 weeks ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
Cannabis1 week ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis2 weeks agoIM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis1 week agoAvicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis1 week ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services
-
Cannabis2 weeks ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
transfer4 days ago
IMC to transfer its Oranim Pharmacy shares back to the seller
